Structure of recombinant human butyrylcholinesterase in complex with a coumarin-based fluorescent probe linked to sulfonamide type inhibitor.

Brain butyrylcholinesterase (BChE) is an attractive target for drugs designed for the treatment of Alzheimer’s disease (AD) in its advanced stages. It also potentially represents a biomarker for pr...

[1]  J. Stojan.  The mechanism and benefit of human butyrylcholinesterase activation by what would otherwise be inhibitors. , 2019, Chemico-biological interactions.

[2]  Yingfu Li,et al.  Discovery of Butyrylcholinesterase-Activated Near-Infrared Fluorogenic Probe for Live-Cell and In Vivo Imaging. , 2018, ACS sensors.

[3]  Jason Weller,et al.  Current understanding of Alzheimer’s disease diagnosis and treatment , 2018, F1000Research.

[4]  J. Kos,et al.  The Magic of Crystal Structure-Based Inhibitor Optimization: Development of a Butyrylcholinesterase Inhibitor with Picomolar Affinity and in Vivo Activity. , 2018, Journal of medicinal chemistry.

[5]  C. Masters,et al.  A systemic view of Alzheimer disease — insights from amyloid-β metabolism beyond the brain , 2017, Nature Reviews Neurology.

[6]  J. Molinuevo,et al.  Alzheimer’s disease prevention: from risk factors to early intervention , 2017, Alzheimer's Research & Therapy.

[7]  J. Stojan.  Rapid Mechanistic Evaluation and Parameter Estimation of Putative Inhibitors in a Single-Step Progress-Curve Analysis: The Case of Horse Butyrylcholinesterase , 2017, Molecules.

[8]  S. Darvesh,et al.  Quantification of Butyrylcholinesterase Activity as a Sensitive and Specific Biomarker of Alzheimer’s Disease , 2017, Journal of Alzheimer's disease : JAD.

[9]  Wenchao Yang,et al.  Discovery of a butyrylcholinesterase-specific probe via a structure-based design strategy. , 2017, Chemical communications.

[10]  J. Kos,et al.  N-Propargylpiperidines with naphthalene-2-carboxamide or naphthalene-2-sulfonamide moieties: Potential multifunctional anti-Alzheimer's agents. , 2017, Bioorganic & medicinal chemistry.

[11]  J. Kos,et al.  Development of an in-vivo active reversible butyrylcholinesterase inhibitor , 2016, Scientific Reports.

[12]  P. Renard,et al.  A selective and sensitive near-infrared fluorescent probe for acetylcholinesterase imaging. , 2016, Chemical communications.

[13]  S. Turk,et al.  Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor. , 2014, Journal of medicinal chemistry.

[14]  Nick C Fox,et al.  Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria , 2014, The Lancet Neurology.

[15]  J. Stojan.  The significance of low substrate concentration measurements for mechanistic interpretation in cholinesterases. , 2013, Chemico-biological interactions.

[16]  P. Renard,et al.  Human butyrylcholinesterase produced in insect cells: huprine‐based affinity purification and crystal structure , 2012, The FEBS journal.

[17]  H. Kagechika,et al.  6-arylcoumarins as novel nonsteroidal type progesterone antagonists: an example with receptor-binding-dependent fluorescence. , 2011, Journal of medicinal chemistry.

[18]  N. Goodey,et al.  Development of a fluorescently labeled thermostable DHFR for studying conformational changes associated with inhibitor binding. , 2011, Biochemical and biophysical research communications.

[19]  Matej Praprotnik,et al.  ENZO: A Web Tool for Derivation and Evaluation of Kinetic Models of Enzyme Catalyzed Reactions , 2011, PloS one.

[20]  I. Hamachi,et al.  Montmorillonite-supramolecular hydrogel hybrid for fluorocolorimetric sensing of polyamines. , 2011, Journal of the American Chemical Society.

[21]  B. Kuhn,et al.  A Medicinal Chemist’s Guide to Molecular Interactions , 2010, Journal of medicinal chemistry.

[22]  P. Kuzmič.  Application of the Van Slyke-Cullen irreversible mechanism in the analysis of enzymatic progress curves. , 2009, Analytical biochemistry.

[23]  Paul D Adams,et al.  Electronic Reprint Biological Crystallography Electronic Ligand Builder and Optimization Workbench (elbow ): a Tool for Ligand Coordinate and Restraint Generation Biological Crystallography Electronic Ligand Builder and Optimization Workbench (elbow): a Tool for Ligand Coordinate and Restraint Gener , 2022 .

[24]  J. Grosche,et al.  A gorge-spanning, high-affinity cholinesterase inhibitor to explore beta-amyloid plaques. , 2009, Organic & biomolecular chemistry.

[25]  C. Geula,et al.  Butyrylcholinesterase activity in the rat forebrain and upper brainstem: Postnatal development and adult distribution , 2007, Experimental Neurology.

[26]  Z. Darżynkiewicz,et al.  Novel Assay Utilizing Fluorochrome-Tagged Physostigmine (Ph-F) to In Situ Detect Active Acetylcholinesterase (AChE) Induced during Apoptosis , 2005, Cell cycle.

[27]  A. W. Schüttelkopf,et al.  PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. , 2004, Acta crystallographica. Section D, Biological crystallography.

[28]  B. Imperiali,et al.  A new environment-sensitive fluorescent amino acid for Fmoc-based solid phase peptide synthesis. , 2004, Organic & biomolecular chemistry.

[29]  C. Geula,et al.  Neurobiology of butyrylcholinesterase , 2003, Nature Reviews Neuroscience.

[30]  Luke G Green,et al.  A stepwise huisgen cycloaddition process: copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes. , 2002, Angewandte Chemie.

[31]  Morten Meldal,et al.  Peptidotriazoles on solid phase: [1,2,3]-triazoles by regiospecific copper(i)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides. , 2002, The Journal of organic chemistry.

[32]  P. Taylor,et al.  Synthesis of fluorescent probes directed to the active site gorge of acetylcholinesterase. , 2000, Bioorganic & medicinal chemistry letters.

[33]  D. Hopkins,et al.  Distribution of butyrylcholinesterase in the human amygdala and hippocampal formation , 1998, The Journal of comparative neurology.

[34]  Y. Ashani,et al.  New fluorescent organophosphates as probes for studying aging-induced conformational changes in inhibited acetylcholinesterase , 1980, Neurochemistry International.

[35]  K. Courtney,et al.  A new and rapid colorimetric determination of acetylcholinesterase activity. , 1961, Biochemical pharmacology.

[36]  G B KOELLE,et al.  A Histochemical Method for Localizing Cholinesterase Activity.* , 1949, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[37]  A. Sharff,et al.  Data processing and analysis with the autoPROC toolbox , 2011, Acta crystallographica. Section D, Biological crystallography.

[38]  P. Emsley,et al.  Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.

[39]  W. Kabsch.  Integration, scaling, space‐group assignment and post refinement , 2006 .

[40]  N. Viguié,et al.  Engineering of a monomeric and low-glycosylated form of human butyrylcholinesterase: expression, purification, characterization and crystallization. , 2002, European journal of biochemistry.